avelumab
pfizer,merck
[' uc,(-ucsd),(-ucsf),', 'avelumab', 'bladder', 'urothelial']
avelumab first-line maintenance linked to long-term os benefit in uc regardless of receipt of second-line treatment #asco22 #urology #urologist #urothelialcarcinoma #bladdercancer 
Expert clinical analysis. Practice advice. Policy perspectives.